glp 1 dry eyes GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk GLP-1 Medications and Your Vision:

The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials

Early experimental data raised concerns of a possible risk of medullary thyroid carcinoma, whereas data from randomized trials suggest a possible increase in risk of non-medullary thyroid carcinoma

If you suspect you injected significantly more than your prescribed dose, contact your healthcare provider or poison control immediately

An effect was observed at T0 before the glucose challenge but already after 30 min (60 min after dosing) there was no significant effect on the blood glucose for peptide 1 in agreement with previous IPGTT study